Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Orion Oyj is a globally operating Finnish pharmaceutical company founded in 1917 and headquartered in Espoo, Finland. It specializes in the research, development, manufacturing, and marketing of human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients. The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases, serving customers such as specialists, general practitioners, veterinarians, pharmacies, hospitals, and laboratories. While its core market is Finland, Orion Oyj maintains a significant presence in other European countries, North America, and additional regions. With approximately 3,989 employees, it operates within the pharmaceuticals and biotech sector, contributing to healthcare innovation through its mid-cap profile and emphasis on specialized therapeutics. Orion Oyj's product portfolio underscores its role in addressing critical medical needs across human and animal health domains.